IRIS
PEA, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.898
EU - Europa 3.858
AS - Asia 3.044
SA - Sud America 443
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 2
Totale 22.303
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.817
UA - Ucraina 1.127
SG - Singapore 1.070
CN - Cina 802
DE - Germania 608
HK - Hong Kong 577
IT - Italia 561
SE - Svezia 485
BR - Brasile 403
RU - Federazione Russa 336
TR - Turchia 285
IE - Irlanda 214
FI - Finlandia 198
GB - Regno Unito 124
VN - Vietnam 102
IN - India 61
CA - Canada 59
FR - Francia 49
KR - Corea 42
BE - Belgio 38
EU - Europa 21
CZ - Repubblica Ceca 20
NL - Olanda 19
BD - Bangladesh 14
EG - Egitto 14
ES - Italia 13
IR - Iran 12
MX - Messico 11
ID - Indonesia 10
IQ - Iraq 10
JP - Giappone 10
RO - Romania 10
AR - Argentina 9
CH - Svizzera 8
PL - Polonia 8
ZA - Sudafrica 8
CO - Colombia 7
EC - Ecuador 7
AT - Austria 6
PK - Pakistan 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
IL - Israele 5
PT - Portogallo 5
RS - Serbia 5
UZ - Uzbekistan 5
VE - Venezuela 5
JM - Giamaica 4
MA - Marocco 4
PE - Perù 4
TG - Togo 4
TH - Thailandia 4
BG - Bulgaria 3
KW - Kuwait 3
LT - Lituania 3
LU - Lussemburgo 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AU - Australia 2
BO - Bolivia 2
CL - Cile 2
CM - Camerun 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
PA - Panama 2
SD - Sudan 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BY - Bielorussia 1
DK - Danimarca 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MK - Macedonia 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
Totale 22.303
Salva come PNG Salva come JPEG
Città #
Fairfield 2.203
Woodbridge 1.561
Chandler 1.139
Houston 1.086
Ashburn 1.058
Ann Arbor 962
Wilmington 839
Seattle 828
Cambridge 715
Jacksonville 635
Singapore 569
Hong Kong 568
Dearborn 427
Beijing 400
Boardman 349
Izmir 268
Princeton 237
Dublin 214
Udine 194
Des Moines 173
San Diego 125
Dong Ket 71
Munich 70
Falls Church 58
Redmond 57
Hefei 51
New York 48
Norwalk 43
Los Angeles 41
Ogden 40
Brussels 37
Seoul 35
Nanjing 34
Grafing 33
São Paulo 32
Ottawa 27
Shanghai 26
Helsinki 23
Moscow 23
Grugliasco 22
Dallas 20
Kunming 20
Guangzhou 19
Jinan 17
Milan 17
Brno 16
San Mateo 15
Santa Clara 15
Trieste 15
Brasília 14
Brooklyn 14
London 14
Nuremberg 14
Bologna 13
Düsseldorf 13
Montreal 13
Piemonte 12
West Jordan 12
Wuhan 12
Hanoi 11
Nanchang 11
Phoenix 11
Redwood City 11
Rio de Janeiro 11
San Francisco 11
Amsterdam 10
Belo Horizonte 10
Fuzhou 10
Naples 10
Rome 10
Tokyo 10
Turku 10
Augusta 9
Changsha 9
Frankfurt am Main 9
Simi Valley 9
Venezia 9
Chicago 8
Curitiba 8
Lauterbourg 8
Toronto 8
Warsaw 8
Campinas 7
Hyderabad 7
Monmouth Junction 7
Turin 7
Verona 7
Washington 7
Bogor 6
Boston 6
Dhaka 6
Portsmouth 6
San Jose 6
Tappahannock 6
Zurich 6
Andover 5
Auburn Hills 5
Brescia 5
Chengdu 5
Hangzhou 5
Totale 15.936
Salva come PNG Salva come JPEG
Nome #
A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients? 363
A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds? 363
A regional approach to Antimicrobial Stewardship: the Friuli Venezia Giulia program 230
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? 201
Everolimus overexposure in a heart transplant patient receiving clarithromycin for the treatment of pneumonia 183
LONG-TERM OUTCOMES OF ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS AND COMPARISON WITH HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE CASES 177
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant 174
Educational and Organizational Interventions to Improve the Usefulness of Clinical Pharmacological Advice for Personalized Drug Dosing Based on Therapeutic Drug Monitoring. 166
Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with hematological malignancies 161
Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures. 159
Polypharmacy in an Italian Regional Health system: a survey on drugs use in different healthcare settings 159
Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients 158
Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients 157
Antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: dose intensification coupled with avoidance of proton pump inhibitors is beneficial in shortening time to effective concentrations. 153
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 147
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 146
Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients 145
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 145
Population pharmacokinetics and pharmacodynamics of levofloxacin in acutely hospitalized older patients with various degrees of renal function 145
Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing Regimens 144
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy 144
Linezolid underexposure in a patient co-treated with venlafaxine 139
Ceftolozane/tazobactam: place in therapy 139
What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice? 135
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis 133
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience 133
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia. 133
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections 133
Antibiotic therapy in hematological neutropenic patients: what is the news? 132
Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient 130
Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus. 130
- FLUCONAZOLE MONITORING IN LIVER TRANSPLANT RECIPIENTS 128
Is MIC increase of meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae correlated with the increase of resistance rates against some other antibiotics with Gram-negative activity? 128
Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases. 127
Pharmacokinetic drug interaction between everolimus and antifungal triazoles in a liver transplant patient 127
Treatment of consecutive episodes of multidrug-resistant bacterial pleurisy with different aetiology in a heart transplant candidate: Proof of concept of pharmacokinetic/pharmacodynamic optimisation of antimicrobial therapy at the infection site 127
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers. 126
Pharmacokinetics and drug metabolism of antibiotics in the elderly 126
Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis 125
Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp 125
Major role of levofloxacin in the treatment of a case of Listeria monocytogenes meningitis 124
Biliary pharmacodynamic exposure to linezolid in two liver transplant patients. 124
Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB? 124
Monitoring polypharmacy in healthcare systems through a multi-setting survey: Should we put more attention on long term care facilities? 124
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 124
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions 123
Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients 122
Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations 122
Disposition of ceftobiprole during continuous venous-venous hemodiafiltration (CVVHDF) in a single critically ill patient 121
Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment? 120
Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis 120
Antimicrobial treatment of bacterial infections in frail elderly patients: The difficult balance between efficacy, safety and tolerability 119
Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: A case report 119
High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures 118
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis 118
HIV-INFECTED PATIENTS AND LIVER TRANSPLANTATION: WHO, WHEN AND WHY 117
Effect of fluctuations of blood cyclosporine concentrations on renal function. 117
Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation. 117
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections 116
Plasma pharmacokinetics of antimicrobial agents in critically Ill patients 115
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance 115
Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery 114
Candida endocarditis and the impact of antifungal treatment on the corrected QT interval: a case report 114
Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): Comparative pharmacokinetics and the role of therapeutic drug monitoring 114
Practical concept of pharmacokinetics/pharmacodynamics in the management of skin and soft tissue infections 114
Urinary Pharmacokinetics and Theoretical Pharmacodynamics of Intravenous Levofloxacin in Intensive Care Unit Patients Treated with 500 mg b.i.d. for Ventilator-Associated Pneumonia 114
Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia 113
Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy 113
Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter? 112
The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin 112
Drugs and blood cells 112
Procalcitonin-guided antibiotic therapy: An expert consensus 112
A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy 112
Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats 111
Teicoplanin therapeutic drug monitoring in critically ill patients: A retrospective study emphasizing the importance of a loading dose 110
Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: A pharmacokinetics/pharmacodynamics-based approach 110
The effect of pathophysiology on pharmacokinetics in the critically ill patient - Concepts appraised by the example of antimicrobial agents 110
Daptomycin in solid organ transplantation: Consideration of dosage adjustments in renal impairment 110
Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin 110
Blood concentrations and clinical effect of cyclosporin in psoriasis 109
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 109
Gentamicin once-daily in enterococcal endocarditis 109
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring 109
A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care 109
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective 108
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 107
Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients 107
Effect of the number of samples on bayesian and non-linear least-squares individualization: A study of cyclosporin treatment of haematological patients with multidrug resistance 106
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 105
Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review 104
A Comparative Analysis of the Urinary Excretion Profiles of Mesna and Argimesna Following Oral Administration to Healthy Volunteers 104
Reappraisal of Linezolid Dosing in Renal Impairment to Improve Safety 104
Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patients 104
Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections 103
Higher than standard meropenem and linezolid dosages needed for appropriate treatment of an intracerebral hemorrhage patient with augmented renal clearance 103
Could de-escalation of antibiotic therapy be feasible even for documented methicillin-resistant staphylococcus aureus ventilator-associated pneumonia? 103
TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients 103
Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies 102
Serum concentrations of sodium 2-mercaptoethanesulfonate (MESNA) and its metabolite, disulfide form (DIMESNA), in volunteers after oral dosing: A comparison between mesna and argimesna 102
Pharmacokinetic-pharmacodynamic aspecte of antimicrobial prophylaxis with teisoplanin in patients undergoing major vascular surgery 102
Totale 13.044
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.882
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.375 220 431 130 383 229 345 166 362 392 140 322 255
2021/20222.225 116 198 145 170 88 118 153 104 33 372 402 326
2022/20232.555 274 152 38 332 313 741 0 174 369 27 67 68
2023/2024668 126 53 20 10 114 79 20 57 71 40 28 50
2024/20253.674 111 318 216 126 137 198 189 253 433 281 470 942
2025/2026233 233 0 0 0 0 0 0 0 0 0 0 0
Totale 22.993